Neurotrophins Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Neurotrophins are the neurotrophic factors that are small proteins which induce the growth, survival and function of the neurons. It regulate axon growth, dendrite pruning and protein expression that are important for basic neurological function. These proteins are secreted in nervous system at extremely low concentrations inorder to keep the nerve cells alive. Neurotrophins has been widely used for treatment of various chronic neurological disorders like Parkinson's disease, Alzheimer's disease etc. by regulating the cell death pathway. Neurotrophins induce progenitor cells differentiation to form neurons.

MARKET SCOPE

The "Global Neurotrophins Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the neurotrophins market with detailed market segmentation by product type, application, end-user, and geography. The report provides key statistics on the market status of the leading neurotrophins market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on product type, the global neurotrophins market is segmented into nerve growth factor, brain-derived neurotrophic factor, dehydroepiandrosterone sulfate, and other.
  
•  On the basis of application, the market is segmented into alzheimer's disease, amyotrophic lateral sclerosis, parkinson's disease, and other.
  
•  On the basis of end-users, the market is bifurcated into hospitals, diagnostic centers, and others.
  

MARKET DYNAMICS

Drivers:

•  Rising prevalence of chronic neurological diseases drive the neurotrophins market.
  
•  Growing geriatric population globally boosts the growth of neurotrophins market.
  
•  Increasing awareness regarding mental health fuel the demand for neurotrophins market.
  
•  Increasing research and drug development funding to various pharmaceutical industries in developed countries and growing product launch propel the growth of the market.
  

Restraints:

•  Lack of high healthcare infrastructure in under developing countries.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The neurotrophins market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the neurotrophins market in these regions.

IMPACT OF COVID-19 ON NEUROTROPHINS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Firstly, the COVID-19 had a negative impact on the market. With the number of rising cases, the healthcare workers have to perform alternative roles in order to meet the demand raised due to the outbreak and serve as many patients as possible. Worldwide surgeries being postponed due to the pandemic and only essentials surgeries were allowed. However, due to upliftment of imposed restrictive measure the market may witness slow and steady growth in forecast period.

MARKET PLAYERS

The report covers key developments in the neurotrophins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from neurotrophins market are anticipated to have lucrative growth opportunities in the future with the rising demand for neurotrophins in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the neurotrophins market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  R&D Systems
  
•  Antigenix America Inc.
  
•  Johnson?Johnson
  
•  PeproTech
  
•  FibroGen
  
•  Merck Serono
  
•  Janssen Biotech, Inc.,
  
•  GE Healthcare
  
•  Scil Proteins GmbH
  
•  Lonza Groups
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Neurotrophins Report Scope